Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
31%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
IHE
36
HOLDINGS
17%
ALSO IN MEDX
MEDX
28
HOLDINGS
21%
ALSO IN IHE
SECTOR DRIFT (IHE minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IHE |
Weight in MEDX |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 18.8% | 13.9% | 13.9% | |
JOHNSON & JOHNSON | 24.6% | 5.0% | 5.0% | |
BRISTOL-MYERS SQUIBB CO | 4.1% | 4.7% | 4.1% | |
PFIZER INC | 4.5% | 3.9% | 3.9% | |
MERCK & CO. INC. | 4.6% | 3.4% | 3.4% |
IHE Overweight Relative to MEDX
JOHNSON & JOHNSON | 19.6% | |
VIATRIS, INC. | 4.8% | |
ELI LILLY & CO | 4.8% | |
ROYALTY PHARMA PLC CLASS A | 4.5% | |
ELANCO ANIMAL HEALTH, INC. | 4.1% | |
ZOETIS INC | 4.0% | |
JAZZ PHARMACEUTICALS PLC | 3.5% | |
CORCEPT THERAPEUTICS INC | 3.1% | |
AXSOME THERAPEUTICS, INC. | 2.3% | |
PERRIGO CO | 1.6% |
IHE Underweight Relative to MEDX
ABBVIE INC | -9.4% | |
NOVARTIS AG-ADR | -7.1% | |
ALNYLAM PHARMACEUTICALS INC | -6.6% | |
ASTRAZENECA PLC-SPONS ADR | -5.4% | |
AMGEN INC | -4.0% | |
ALKERMES PLC | -4.0% | |
CRISPR THERAPEUTICS AG | -3.3% | |
IONIS PHARMACEUTICALS, INC. | -3.1% | |
GLAXOSMITHKLINE PLC-SPON ADR | -2.6% | |
BIOGEN IDEC INC | -2.5% |